1-[(3,4-dichlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazole | 878974-35-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 1-[(3,4-dichlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazole
• 英文别名: 1-(3,4-dichlorobenzyl)-5,6-dimethyl-1H-benzo[d]imidazole；1-(3,4-dichlorobenzyl)-5,6-dimethyl-1H-benzimidazole；1-[(3,4-dichlorophenyl)methyl]-5,6-dimethylbenzimidazole
• CAS: 878974-35-7
• 化学式: C₁₆H₁₄Cl₂N₂
• 分子量: 305.207
• InChiKey: PCJBTWVYIQBUCM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5
• 重原子数：
  20
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.19
• 拓扑面积：
  17.8
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  5,6-二甲基苯并咪唑 、 3,4-二氯苄溴 在 sodium hydride 、 potassium iodide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 16.0h， 生成 1-[(3,4-dichlorophenyl)methyl]-5,6-dimethyl-1H-1,3-benzodiazole
  参考文献：
  名称：

  The benzimidazole based drugs show good activity against T. gondii but poor activity against its proposed enoyl reductase enzyme target

  摘要：

  The enoyl acyl-carrier protein reductase (ENR) enzyme of the apicomplexan parasite family has been intensely studied for antiparasitic drug design for over a decade, with the most potent inhibitors targeting the NAD(+) bound form of the enzyme. However, the higher affinity for the NADH co-factor over NAD(+) and its availability in the natural environment makes the NADH complex form of ENR an attractive target. Herein, we have examined a benzimidazole family of inhibitors which target the NADH form of Francisella ENR, but despite good efficacy against Toxoplasma gondii, the IC50 for T. gondii ENR is poor, with no inhibitory activity at 1 μM. Moreover similar benzimidazole scaffolds are potent against fungi which lack the ENR enzyme and as such we believe that there may be significant off target effects for this family of inhibitors.

  DOI：

  10.1016/j.bmcl.2013.12.066

文献信息

• 一种基于铁催化氧化还原偶联反应的苯并咪 唑类化合物合成方法
  申请人：中国农业大学

  公开号：CN111704579B

  公开（公告）日：2021-12-14

  本发明属于有机合成领域，涉及一种基于铁催化氧化还原偶联反应的苯并咪唑类化合物合成方法。该方法以邻硝基苯胺类化合物、醇类化合物为原料，在铁催化剂和质子供体存在的条件下，通过铁催化的氧化还原偶联反应，生成苯并咪唑类化合物。本发明所述的方法为苯并咪唑类药物和农药的合成提供了新的途径。相比传统的以邻苯二胺类化合物和羧酸或羧酸衍生物为原料的苯并咪唑类化合物合成方法，本发明所述的方法提高了整个流程的原子利用率，降低了生产成本和生产过程中产生的“三废”污染。
• Methanol as the C₁ source: redox coupling of nitrobenzenes and alcohols for the synthesis of benzimidazoles
  作者：Hengzhao Li、Yuntong Zhang、Zihan Yan、Zemin Lai、Ruoyan Yang、Mengqi Peng、Yanhao Sun、Jie An

  DOI：10.1039/d1gc03907e

  日期：——

  We present an operationally simple redox coupling for the synthesis of N-1 substituted benzimidazoles using feedstock building block 2-nitroaniline derivatives as the precursors and methanol as the C1 source. Higher atom, step, and redox economies and excellent regioselectivity were achieved compared with conventional synthesis using diaminobenzene and formic acid derivatives.

  我们提出了一种操作简单的氧化还原偶联，用于合成 N-1 取代的苯并咪唑，使用原料构建块 2-硝基苯胺衍生物作为前体，甲醇作为 C 1源。与使用二氨基苯和甲酸衍生物的常规合成相比，实现了更高的原子、步骤和氧化还原经济性以及出色的区域选择性。
• Methods and compositions of treating a flaviviridae family viral infection
  申请人：Einav Shirit

  公开号：US20100028299A1

  公开（公告）日：2010-02-04

  Briefly described, embodiments of this disclosure include compounds, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of inhibiting HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.

  简要描述，本公开涉及的实施例包括化合物、制药组合物、治疗感染黄病毒科病毒的宿主的方法、抑制宿主中HCV复制的方法、抑制NS4B多肽与HCV负链RNA的3'UTR结合的方法、治疗宿主肝纤维化的方法等。
• METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION, AND SCREENING ASSAYS FOR IDENTIFYING COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION
  申请人：Quake Stephen R.

  公开号：US20100260717A1

  公开（公告）日：2010-10-14

  Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of identifying a candidate agent for the treatment of hepatitis C virus (HCV) infection, and the like.
• METHODS OF TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION AND COMPOSITIONS FOR TREATING A FLAVIVIRIDAE FAMILY VIRAL INFECTION
  申请人：Einav Shirit

  公开号：US20110052536A1

  公开（公告）日：2011-03-03

  Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of treating HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.